[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100615675":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":20,"locations":26,"responsibleParty":41,"collaborators":19,"id":45,"slug":19,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":19,"eligibilityCriteria":50,"healthyVolunteers":46,"sex":51,"minAge":19,"maxAge":52,"enrollmentInfo":53,"targetDuration":19,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":19,"overallStatus":28,"whyStopped":19,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"The General Authority for Teaching Hospitals and Institutes","NETWORK",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Study group","EXPERIMENTAL","Participants will receive eye drops prepared from their blood serum following a standardized protocol. Specifically, 40 mL of venous blood was collected from each participant at the start of the study and centrifuged at 3000 rpm for 15 min.",[13],"Other: Autologous Serum Eye Drop",[15],{"type":16,"name":17,"description":11,"armGroupLabels":18,"otherNames":19},"OTHER","Autologous Serum Eye Drop",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Hossam A Hassan, MD","CONTACT","00201026808348","Dr.hossameabdalfataah@gothi.gov.eg",[27],{"facility":5,"status":28,"city":29,"state":19,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"RECRUITING","Cairo","11562","Egypt","EG",{"type":34,"coordinates":35},"Point",[36,37],31.24967,30.06263,{"lat":37,"lon":36},[40],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},{"type":42,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"PRINCIPAL_INVESTIGATOR","Hossam Abdelfattah Husein Hassan","Fellow of Ophthalmology, Sohag Teaching Hospital, Egypt.","100615675",false,"NCT07295691","Autologous Serum Eye Drops in Dry Eye Syndrome","Autologous Serum Eye Drops in Dry Eye Syndrome: Clinical Efficacy and Safety Evaluation","Inclusion Criteria:\n\n* Children aged less than 18 years.\n* Both sexes.\n* Diagnosed with moderate to severe dry eye syndrome (DES) refractory to artificial tears.\n\nExclusion Criteria:\n\n* Active ocular infection.\n* Recent ocular surgery.\n* Systemic immunosuppressive therapy.\n* History of allergy to blood-derived products.","ALL","18 Years",{"count":54,"type":55},70,"ESTIMATED","INTERVENTIONAL",[58],"NA","This study aims to evaluate the clinical efficacy and safety of autologous serum eye drops (ASEDs) in patients with moderate-to-severe dry eye syndrome who are refractory to conventional artificial tear therapy.",[61,62],"Autologous Serum Eye Drops","Dry Eye Syndrome","2025-12-06",{"date":65,"type":66},"2025-12-22","ACTUAL",{"date":68,"type":66},"2025-09-01",{"date":70,"type":55},"2025-12-31",{"name":5,"class":6},1]